We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$2.7B
1-Year Est. Return
29.67%
This Fund
S&P 500
This Quarter
Est. Return
+13.94%
1 Year Est. Return
+29.67%
3 Year Est. Return
+102.72%
5 Year Est. Return
+136.36%
10 Year Est. Return
+453.01%
AUM
$1.33B
AUM Growth
+$36.1M
(+2.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-8.68%
Top 10 Holdings %
Top 10 Hldgs %
37.57%
Holding
362
New
48
Increased
85
Reduced
71
Closed
21
Top Buys
| 1 |
Amgen
AMGN
|
+$3.78M |
| 2 |
Viatris
VTRS
|
+$1.26M |
| 3 |
WEX
WEX
|
+$553K |
| 4 |
Unilever
UL
|
+$539K |
| 5 |
CACI
CACI
|
+$527K |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$45.3M |
| 2 |
Apple
AAPL
|
+$33.7M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.46M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$8.41M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$7.55M |
Sector Composition
| 1 | Technology | 25.03% |
| 2 | Industrials | 15.85% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Financials | 11.67% |
| 5 | Healthcare | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Semtech
SMTC
$13.2B
| $387K | 0.03% |
5,365
-809
| -13% | -$51.7K |
|
202
Halozyme
HALO
$8.9B
| $386K | 0.03% |
9,040
+988
| +12% | +$35.5K |
|
203
American Express
AXP
$242B
| $378K | 0.03% |
+3,125
| New | +$346K |
|
204
Credicorp
BAP
$31.2B
| $377K | 0.03% |
2,299
-743
| -24% | -$103K |
|
205
Azenta
AZTA
$1.17B
| $373K | 0.03% |
5,494
-1,532
| -22% | -$95.5K |
|
206
NVIDIA
NVDA
$5.13T
| $373K | 0.03% |
28,560
-3,640
| -11% | -$48.7K |
|
207
Spire
SR
$4.81B
| $369K | 0.03% |
5,761
| – | – |
|
208
US Bancorp
USB
$96.8B
| $368K | 0.03% |
7,897
-3,151
| -29% | -$133K |
|
209
CoStar Group
CSGP
$11.3B
| $368K | 0.03% |
3,980
-430
| -10% | -$37.7K |
|
210
Texas Roadhouse
TXRH
$12.4B
| $366K | 0.03% |
4,679
| – | – |
|
211
Minerals Technologies
MTX
$2.24B
| $365K | 0.03% |
5,873
| – | – |
|
212
Merit Medical Systems
MMSI
$4.24B
| $365K | 0.03% |
6,572
-755
| -10% | -$39K |
|
213
NorthWestern Energy
NWE
$4.48B
| $364K | 0.03% |
6,239
| – | – |
|
214
CONMED
CNMD
$1.26B
| $363K | 0.03% |
3,244
| – | – |
|
215
American Eagle Outfitters
AEO
$2.71B
| $362K | 0.03% |
18,046
| – | – |
|
216
Kadant
KAI
$3.54B
| $362K | 0.03% |
2,568
-746
| -23% | -$95K |
|
217
ING
ING
$93.7B
| $361K | 0.03% |
38,237
| – | – |
|
|
BPMC
218
DELISTED
Blueprint Medicines
BPMC
| $359K | 0.03% |
3,201
+641
| +25% | +$67.6K |
|
219
American Tower
AMT
$78.7B
| $353K | 0.03% |
1,572
+8
| +0.5% | +$1.86K |
|
220
Sherwin-Williams
SHW
$81B
| $351K | 0.03% |
1,434
+108
| +8% | +$25.6K |
|
221
Lowe's Companies
LOW
$116B
| $351K | 0.03% |
2,185
| – | – |
|
|
EFOR
222
Everforth Inc
EFOR
$702M
| $346K | 0.03% |
4,148
| – | – |
|
223
Travere Therapeutics
TVTX
$5.31B
| $346K | 0.03% |
12,706
-2,497
| -16% | -$58.3K |
|
224
McKesson
MCK
$94.1B
| $346K | 0.03% |
1,989
+5
| +0.3% | +$833 |
|
225
Linde
LIN
$242B
| $345K | 0.03% |
1,309
| – | – |
|
Similar funds
TPSF
CI
GIA
PCM
SFS
HCM
NB
WGI